期刊文献+

壳聚糖与知母配伍对糖尿病小鼠晚期糖化终末产物的影响 被引量:2

Effects of Chitosan and It's Rhizoma anemarrhenae Mixture on Advanced Glycosylation End Products (AGEs) of Diabetic Mice
下载PDF
导出
摘要 目的:探讨壳聚糖及其与知母配伍对糖尿病小鼠晚期糖化终末产物的抑制和降糖作用。方法:四氧嘧啶腹腔注射建立糖尿病小鼠模型,将小鼠分为正常组(normal)、模型组(model)、壳聚糖组、壳聚糖+知母组(高、低),连续灌胃28d,取血清测定生化指标。结果:与正常组相比,模型组血糖、果糖胺、游离脂肪酸、晚期糖化终末产物(AGEs)、MDA明显升高,pH、SOD明显降低。与模型组相比,壳聚糖组MDA、血糖和AGEs明显降低,SOD明显升高;壳聚糖+知母高剂量组MDA显著降低,血糖和AGEs明显降低,SOD明显升高;各组pH值明显升高。结论:壳聚糖及其与知母配伍对糖尿病小鼠有保护作用。 Objective: The purpose was to evaluate the efficacy of chitosan and it's Rhizoma anemarrhenae mixture on regulating blood glucose and advanced glycosylation end products(AGEs) in diabetic mice bodies. Method: Diabetes mellitus model was established by intraeritoneal injecting of alloxan, and the mice were randomly divided into normal group, model group, chitosan group, chitosan + Rhizoma anemarrhenae group(high and low). The mice were treated with drugs intragastrically(ig) for 28 days, the following parameters were evaluated: serum glucose, fructosamine, free fatty acid(FFA), serum advanced glycosylation end products(AGEs), serum SOD and MDA. Results: Compared with normal group, the blood glucose, AGEs ,fructosamine, FFA, MDA in model group were increased, while pH and SOD was decreased in the model group. Compared with model group, MDA, blood glucose, AGEs and FFA were reduced, while SOD were increased in chitosan or the higher mixture group, the PH were increased in the treatment groups, and no significant differences were tested of fructosamine in the treatment groups. Conclusion: Chitosan, chitosan + Rhizoma anemarrhenae could protect the diabetic mice by reducing blood glucose and blood AGEs.
出处 《食品科学》 EI CAS CSCD 北大核心 2007年第9期553-555,共3页 Food Science
基金 北京市教育委员会科技发展计划资助项目(KM200611417013) 北京联合大学生物化学工程学院生物化工重点建设学科项目(0660415) 北京市人才引进计划项目
关键词 壳聚糖 知母 晚期糖化终末产物 血糖 果糖胺 chitosan Rhizoma anemarrhenae AGEs blood glucose fructosamine
  • 相关文献

参考文献8

  • 1PITTLER M H, ABBOT N C, HARKNESS E F, et al. Randomized, double-blind trial of chitosan for body weight reduction[J]. European Journal of Clinical Nutrition, 1999, 53: 379-381.
  • 2LEE H W, PARK Y S, CHOI J W, et al. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced oninsulin-dependent diabetes mellitus in rats[J]. Biol Pharm Bull, 2003, 26(8): 1100-1114.
  • 3VLASSARA H. Recent progress in advangced glycation end products and disbetic complications[J]. Diabetes, 1997, 46(Suppl): 19-25.
  • 4EDELSTEIN D, BROWNLEE M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine[J]. Diabetes, 1992, 41(1): 26-29.
  • 5张剑锋,赵晓琴,刘唐威.老年人糖尿病酮症酸中毒时测定血尿素氮和pH值的临床意义[J].广西医科大学学报,2003,20(1):42-43. 被引量:3
  • 6AUSAR S F, MORCILLO M, LEON A E. Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan[J]. J Med Food, 2003, 6(4): 397-399.
  • 7SCHMIDT A M, YAN S D, WAUTIER J L, et al. Activation of receptor for advanced glycation end product: Amcchanism for hrortic vascular dysfunction in diabetic vasculopathy and artherosclerosis[J]. Circulation Research, 1999, 84(5): 489-497.
  • 8UCALA R, MAKITA Z, KOSCHINSKY T, et al. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo[J]. Proc Natl Acad Sci, 1993, 90: 6334-6338.

二级参考文献3

共引文献2

同被引文献73

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部